Evidence map›Paper›PMID 29904224›Full record

ArticleBulletin of the World Health Organization2018

The global burden of kidney disease and the sustainable development goals.

Valerie A Luyckx, Marcello Tonelli, John W Stanifer

3 registry-linked trialsOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bulletin of the World Health Organization, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 392 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
392citing papers in PubMed, 13 pooled it
126.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04389827 completednot on this mapstarted 2020, after this paper: background citation

Global Kidney Patient Trials Network

Typeobservational_patient_registrySponsorThe George InstituteRan2020 to 2025Enrolled5,999ConditionsKidney Diseases
NCT04709770 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Comparison of Low-volume Versus High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis: a Randomized Non-inferiority Trial

TypeinterventionalSponsorAlfredo Di LeoRan2021 to 2022Enrolled264ConditionsChronic Kidney Diseases, Colon Polyp, Dialysis, ComplicationsArms2-liters polyethylene glycol with citrate and simethicone, 4-liters polyethylene glycol with simethicone, Low-residue diet
NCT05036850 recruitingnot on this mapstarted 2021, after this paper: background citation

China Kidney Patient Trials Network

Typeobservational_patient_registrySponsorGeorge (Beijing) Clinical Research Co. Ltd.Ran2021 to 2031Enrolled1,200ConditionsKidney Diseases
3 · Its place in the literature

Who cites it

392 citing papers in PubMed, 13 syntheses or guidelines pooled it, 903 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

332 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Valerie A LuyckxInstitute of Biomedical Ethics and History of Medicine, University of Zurich, Winterthurerstrasse 30, 8006 Zurich, Switzerland.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Canada.
John W StaniferDepartment of Medicine, Duke University, Durham, United States of America.
Duke University · USUniversity of Calgary · CAUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney disease has been described as the most neglected chronic disease. Reliable estimates of the global burden of kidney disease require more population-based studies, but specific risks occur across the socioeconomic spectrum from poverty to affluence, from malnutrition to obesity, in agrarian to post-industrial settings, and along the life course from newborns to older people. A range of communicable and noncommunicable diseases result in renal complications and many people who have kidney disease lack access to care. The causes, consequences and costs of kidney diseases have implications for public health policy in all countries. The risks of kidney disease are also influenced by ethnicity, gender, location and lifestyle.  Increasing economic and health disparities, migration, demographic transition, unsafe working conditions and environmental threats, natural disasters and pollution may thwart attempts to reduce the morbidity and mortality from kidney disease. A multisectoral approach is needed to tackle the global burden of kidney disease. The sustainable development goals (SDGs) emphasize the importance of a multisectoral approach to health. We map the actions towards achieving all of the SDGs that have the potential to improve understanding, measurement, prevention and treatment of kidney disease in all age groups. These actions can also foster treatment innovations and reduce the burden of such disease in future generations.

Indexed as

Conservation of Natural ResourcesGlobal HealthGoalsFemaleHumansInfant, NewbornKidney DiseasesMaleMorbidityMortality

Identifiers

PMID29904224
PMCPMC5996218
OpenAlexW2805564751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.